DNLI: Denali Therapeutics Inc. Company Short-Term Debt
The high concentration of early-stage biotech risks within the neurodegenerative programs of Denali Therapeutics (DNLI) is partially offset by strategic partnerships. Denali Therapeutics (DNLI) develops treatments for Alzheimer's and Parkinson's diseases using a unique method to cross the blood-brain barrier. This short-term debt chart confirms the financial dynamics, where the value of 0.01 serves as the current metric. A diversification strategy focusing on rare metabolic disorders in collaboration with pharma behemoths helps optimize research and development costs.
Financial and market metric breakdowns for Denali Corp (DNLI)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Debt to Equity Denali Therapeutics|DNLI - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Denali Therapeutics|DNLI - Company Aggregate Debts|Debt to Book Capitalization Ratio Denali Therapeutics Inc.|DNLI - Company Long-Term Debt|Company Short-Term Debts Denali Therapeutics|Quick Liquidity Indicator denalitherapeutics.com
- net income and valuation multiples indicators:
Analysis of all company metrics:DNLI - Denali Therapeutics Inc.
Short-term liabilities measure the total payments due within one year, allowing for an assessment of liquidity and the risk of overpaying interest in the event of excessive borrowing. For Denali Therapeutics (DNLI), which delegates the production of neuro-drugs to external contractors, the current financial obligations metric reflects the efficiency of managing partner settlements and the stability of the operational cycle within its R&D model.
Competitor analysis for Denali Therapeutics
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Indebtedness XENE (xenon-pharma.com)|Company Short-Term Debts VKTX|SUPN - Short-Term Debt|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|HRMY: Company Short-Term Indebtedness|Biohaven Ltd. - Company Short-Term Debts|AMLX - Company Short-Term Debts|Trevi Therapeutics, Inc. (TRVI) - Company Short-Term Debt|PRAX (Praxis Precision Medicines Inc) - Company Short-Term Debt|AVXL (Anavex Corp) - Company Short-Term Debts|CeriBell EEG (CBLL) - Short-Term Debt Volume|Company Current Liabilities PRTA (Prothena)|ALEC (alector.com) - Company Short-Term Loans and Borrowings|Annexon - Company Current Liabilities|Amount of Current Liabilities OMER (Omeros Corp)|Neurogene Corp - Company Short-Term Debts|Company Short-Term Loans and Borrowings ACIU (AC Immune Inc)|VYGR: Company Short-Term Debts|Short-Term Debt neumoratx.com (NMRA)|Company Short-Term Debt Scilex|TVGN: Company Short-Term Loans and Borrowings|Company Short-Term Debts ACOG|Company Short-Term Debts cogrx.com (CGTX)|Company Short-Term Debt Inhibikase Therapeutics IKT|SAVA (cassavasciences.com) - Current Liabilities|Assertio Therapeutics - Company Short-Term Debts|Short-Term Debt Coya Therapeutics, Inc.|VTGN (vistagen.com) - Company Current Liabilities|Ovid Therapeutics (OVID) - Company Short-Term Debts|Company Current Liabilities ABOS|CRVO (cervomed.com) - Amount of Current Liabilities|Company Short-Term Debts ATHE|Short-Term Debt Volume clene.com|Company Short-Term Debts PEPG (PepGen)|JUNS - Company Current Liabilities|RLMD - Company Short-Term Debt|Short-Term Debt Volume annovisbio.com ANVS|GRCE: Company Short-Term Debts|Company Short-Term Indebtedness AIFF|Company Short-Term Debt ANEW Medical|Company Short-Term Indebtedness NRSN (NeuroSense Therapeutics, Ltd.)|Company Short-Term Debt Reviva Pharmaceuticals (RVPH)|Company Short-Term Debt MTVA (metaviatx.com)|Company Short-Term Debts NRXS (NeurAxis)|Short-Term Debt Volume Helius Medical Technologies, Inc. (HSDT)|PASG - Company Short-Term Debt|NEUP (Neuphoria Therapeutics Inc.) - Company Short-Term Indebtedness|NERV: Company Short-Term Debts|Short-Term Debt athira.com (ATHA)|Company Current Liabilities ADXN|Company Short-Term Debts Alzamend|Company Short-Term Debt Cyclerion Therapeutics (CYCN)|PTIX (protagenic.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Pasithea Therapeutics Corp. KTTA|Cortigent Inc (CRGT) - Short-Term Debt|Avenue Therapeutics, Inc. - Company Short-Term Debts|BCLI (Brainstorm Cell Therapeutics Inc.) - Company Short-Term Indebtedness|CARA: Company Short-Term Debts|Short-Term Debt Chromocell (CHRO)|Company Short-Term Debt Eliem Therapeutics, Inc.|Company Short-Term Indebtedness ITCI (Intra-Cellular)|Company Short-Term Debts LBPH|Company Short-Term Debts Marinus Pharmaceuticals Inc (MRNS)|Company Short-Term Debt NKGen NKGN|NeuroBo Pharma - Company Short-Term Debt|Sage Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume synaptogen.com SNPX|TRVN (Trevena) - Company Current Liabilities|Vigil Neuroscience, Inc. - Company Short-Term Loans and Borrowings|Company Current Liabilities WENA|CERE (Cerevel Corp) - Amount of Current Liabilities